Heparin-coated extracorporeal circulation with full and low dose heparinization: Comparison of thrombin related coagulatory effects

Artificial Organs

Volumn 25, Issue 6, 2001, Pages 480-485

  Mirow, Nikolas ^a,b   Brinkmann, Thomas ^b   Minami, Kazutomo ^a   Tenderich, Gero ^a   Kleesiek, Knut ^b   Körfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiopulmonary bypass; Coagulation; Coronary bypass surgery; Extracorporeal circulation; Heparin coating; Low molecular weight heparin; Systemic heparinization; Thrombin formation

Indexed keywords

DIMERS; MOLECULAR WEIGHT; POLYSACCHARIDES; SURGERY;

BYPASS SURGERY; CARDIOPULMONARY BYPASS; CORONARY BYPASS; CORONARY BYPASS SURGERY; EXTRACORPOREAL CIRCULATION; HEPARIN COATINGS; HEPARINIZATION; LOW-MOLECULAR WEIGHT HEPARINS; SYSTEMIC HEPARINIZATION; THROMBIN FORMATION;

ENZYMES;

BLOOD CLOTTING FACTOR; D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; THROMBIN;

ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SUCTION; THROMBIN TIME; THROMBOEMBOLISM;

EID: 0034828833     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025006480.x     Document Type: Article

References (25)

1. Thrombosis and artificial surfaces
2. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation
3. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage
4. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study
5. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
6. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model
7. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin
8. Risk and benefit of low systemic heparinization during open heart operations
9. Pathway of platelet protection in heparin-coated devices and its significance for cardiac surgery
10. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation
11. A reevaluation of heparin requirements for cardiopulmonary bypass
12. Surface-bound heparin - Panacea or peril?
13. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass
14. Low heparinization with heparin-bonded bypass circuits: Is it a safe strategy?
15. Heparinbeschichtung des extrakorporalen kreislaufs: Gerinnungsaktivierung, verbrauch und fibrinolyse in einer randomisierten studie an koronarbypasspatienten
16. Cardiopulmonary bypass with low systemic heparinization: An experimental study
17. Reduced blood loss and transfusion requirements with low systemic heparinization: Preliminary clinical results in coronary artery revascularization
18. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits
19. Fibrinogen heterogeneity
20. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass
21. Maintenance of homeostasis in coagulation during cardiopulmonary bypass
22. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass
23. Thrombogenic mechanisms in the human: Fresh insights obtained by immunodiagnostic studies of coagulation markers
24. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass
25. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems